{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T10:34:10Z","timestamp":1723026850929},"reference-count":30,"publisher":"Walter de Gruyter GmbH","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec id=\"j_jpm-2017-0059_s_999\">\n                  <jats:title>Aim:<\/jats:title>\n                  <jats:p>(1) To evaluate the prevalence of inherited thrombophilia in pregnant women with adverse pregnancy outcomes: intrauterine growth retardation (IUGR), preeclampsia (PE) and placental abruption. (2) To assess the impact of inherited thrombophilia on the nature of obstetric complications. (3) To assess levels of protein S, protein C, antithrombin III and homocysteine in pregnant women with adverse pregnancy outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpm-2017-0059_s_998\">\n                  <jats:title>Subjects and methods:<\/jats:title>\n                  <jats:p>The study comprised 162 pregnant women. The patients were divided into three test groups and one control group. In all 162 patients the following tests were completed: activated protein C resistance (APC-R), the level of free protein S, activity of protein C, antithrombin III and the level of homocysteine. The data were statistically analyzed via \u03c7<jats:sup>2<\/jats:sup> of independence or homogeneity test.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpm-2017-0059_s_997\">\n                  <jats:title>Results:<\/jats:title>\n                  <jats:p>In 32 of 162 patients participating in clinical research thrombophilia was diagnosed (10 patients with APC-R, 21 patients with protein S deficiency, one patient with hyperhomocysteinemia): seven patients belonged to the control group and 25 patients had diagnosed adverse pregnancy outcomes (P=0.04). In 32 patients with diagnosed thrombophilia, level of protein S was decreased (P=0.04). Protein S deficiency was diagnosed, when level of protein S was lower than 30% in the second trimester and lower than 24% in the third trimester. The incidence of activated protein C resistance caused by the mutation of factor V Leiden was in six patients (5.9%) with adverse pregnancy outcomes, and in four patients (6.6%) from the control group. Results were not statistically significant. No protein C deficiency was diagnosed (diagnosis: level&lt;60%), but in 50% of patients with thrombophilia level of protein C was over the norm (P=0.02). The level of antithrombin III was often decreased in patients with preeclampsia \u2013 (32.4%), then in the other patients \u2013 (17.2%) (P=0.04), but no patient was diagnosed with antithrombin III deficiency (diagnosis: level&lt;60%).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpm-2017-0059_s_996\">\n                  <jats:title>Conclusions:<\/jats:title>\n                  <jats:p>Tests for thrombophilia should be carried out in women with adverse pregnancy outcomes in their history, who are planning pregnancy, to start anticoagulant prophylaxis. Our study supports the thesis that tests for thrombophilia should be carried out in women with a history of adverse pregnancy outcomes and who are planning a pregnancy to start anticoagulant prophylaxis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1515\/jpm-2017-0059","type":"journal-article","created":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T10:01:37Z","timestamp":1502272897000},"page":"411-417","source":"Crossref","is-referenced-by-count":12,"title":["Adverse pregnancy outcomes and inherited thrombophilia"],"prefix":"10.1515","volume":"46","author":[{"given":"Dominik","family":"D\u0142uski","sequence":"first","affiliation":[{"name":"Chair and Department of Obstetrics and Perinatology , Medical University of Lublin , Street: Jaczewskiego 8 , 20-954 Lublin , Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radzis\u0142aw","family":"Mierzy\u0144ski","sequence":"additional","affiliation":[{"name":"Chair and Department of Obstetrics and Perinatology , Medical University of Lublin , Lublin , Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u017cbieta","family":"Poniedzia\u0142ek-Czajkowska","sequence":"additional","affiliation":[{"name":"Chair and Department of Obstetrics and Perinatology , Medical University of Lublin , Lublin , Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo\u017cena","family":"Leszczy\u0144ska-Gorzelak","sequence":"additional","affiliation":[{"name":"Chair and Department of Obstetrics and Perinatology , Medical University of Lublin , Lublin , Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2017,8,9]]},"reference":[{"key":"2022012815324265055_j_jpm-2017-0059_ref_001","doi-asserted-by":"crossref","unstructured":"Brotman DJ, Deitcher SR, Lip GYH, Matzdorff AC. Virchow\u2019s triad revisited. South Med J. 2004;97:213\u20134.","DOI":"10.1097\/01.SMJ.0000105663.01648.25"},{"key":"2022012815324265055_j_jpm-2017-0059_ref_002","doi-asserted-by":"crossref","unstructured":"Roberts HR. Oscar Ratnoff: his contributions to the golden era of coagulation research. Br J Haematol. 2003;122:180\u201392.","DOI":"10.1046\/j.1365-2141.2003.04459.x"},{"key":"2022012815324265055_j_jpm-2017-0059_ref_003","doi-asserted-by":"crossref","unstructured":"Chandrasekhar N, Osbahr A, Laki K. The mode of action of the Laki-Lorand factor in the clotting of fibrinogen. Biochem Biophys Res Commun. 1964;15:182\u20137.","DOI":"10.1016\/0006-291X(64)90321-3"},{"key":"2022012815324265055_j_jpm-2017-0059_ref_004","unstructured":"Abildgaard U. Olav Egeberg\u2013hereditary antithrombin deficiency and thrombophilia. Tidsskr Nor L\u00e6geforen. 2001;121:604\u20135."},{"key":"2022012815324265055_j_jpm-2017-0059_ref_005","unstructured":"Undas A. Stany nadkrzepliwo\u015bci. In: Gajewski P, Zawilska K, Windyga J, editors. Interna Szczeklika. Medycyna Praktyczna; 2014:1764\u20137."},{"key":"2022012815324265055_j_jpm-2017-0059_ref_006","doi-asserted-by":"crossref","unstructured":"Martinelli I, Taioli E, Cetin I, Marinoni A, Gerosa S, Villa MV, et al. Mutations in coagulation factors in women with unexplained late fetal loss. N Engl J Med. 2000;343:1015\u20138.","DOI":"10.1056\/NEJM200010053431405"},{"key":"2022012815324265055_j_jpm-2017-0059_ref_007","doi-asserted-by":"crossref","unstructured":"Martinelli I, Taioli E, Cetin I, Marinoni A, Gerosa S, Villa MV, et al. Thrombophilias and adverse outcomes of pregnancies. What should a clinician do? N Engl J Med. 1999;340:50\u20132.","DOI":"10.1056\/NEJM199901073400110"},{"key":"2022012815324265055_j_jpm-2017-0059_ref_008","doi-asserted-by":"crossref","unstructured":"Brenner B. Thrombophilia and adverse pregnancy outcome. Obstet Gynecol Clin North Am. 2006;33:443\u201356.","DOI":"10.1016\/j.ogc.2006.05.010"},{"key":"2022012815324265055_j_jpm-2017-0059_ref_009","doi-asserted-by":"crossref","unstructured":"ACOG Practice Bulletin No. 138: Inherited thrombophilias in pregnancy. Obstet Gynecol. 2013;122:706\u201317.","DOI":"10.1097\/01.AOG.0000433981.36184.4e"},{"key":"2022012815324265055_j_jpm-2017-0059_ref_010","doi-asserted-by":"crossref","unstructured":"Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med. 1999;340:9\u201313.","DOI":"10.1056\/NEJM199901073400102"},{"key":"2022012815324265055_j_jpm-2017-0059_ref_011","doi-asserted-by":"crossref","unstructured":"Nurk E, Tell GS, Refsum H, Ueland PM, Vollset SE. Factor V Leiden, pregnancy complications and adverse outcomes: the Hordaland Homocysteine Study. Q J Med. 2006;99:289\u201398.","DOI":"10.1093\/qjmed\/hcl040"},{"key":"2022012815324265055_j_jpm-2017-0059_ref_012","doi-asserted-by":"crossref","unstructured":"Dizon-Townson D, Miller C, Sibai B, Spong CY, Thom E, Wendel G Jr, et al. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus. Obstet Gynecol. 2005;106:517\u201324.","DOI":"10.1097\/01.AOG.0000173986.32528.ca"},{"key":"2022012815324265055_j_jpm-2017-0059_ref_013","doi-asserted-by":"crossref","unstructured":"Currie L, Peek M, McNiven M, Prosser I, Mansour J, Ridgway J. Is there an increased maternal-infant prevalence of factor V Leiden in association with severe pre-eclampsia? Br J Obstet Gynaecol. 2002;109:191\u20136.","DOI":"10.1111\/j.1471-0528.2002.00373.x"},{"key":"2022012815324265055_j_jpm-2017-0059_ref_014","doi-asserted-by":"crossref","unstructured":"D\u2019Elia AV, Driul L, Giacomello R, Colaone R, Fabbro D, Di Leonardo C, et al. Frequency of factor V, prothrombin and methylenetetrahydrofolate reductase gene variants in preeclampsia. Gynecol Obstet Invest. 2002;53:84\u20137.","DOI":"10.1159\/000052998"},{"key":"2022012815324265055_j_jpm-2017-0059_ref_015","doi-asserted-by":"crossref","unstructured":"Kahn SR, Platt R, McNamara H, Rozen R, Chen MF, Genest J Jr, et al. Inherited thrombophilia and preeclampsia within a multicenter cohort: the Montreal Preeclampsia Study. Am J Obstet Gynecol. 2009;200:151.e1\u20139; discussion e1\u20135.","DOI":"10.1016\/j.ajog.2008.09.023"},{"key":"2022012815324265055_j_jpm-2017-0059_ref_016","doi-asserted-by":"crossref","unstructured":"van Pampus MG, Wolf H, Koopman MM, van den Ende A, Buller HR, Reitsma PH. Prothrombin 20210 G: a mutation and Factor V Leiden mutation in women with a history of severe preeclampsia and (H)ELLP syndrome. Hypertens Pregnancy. 2001;20:291\u20138.","DOI":"10.1081\/PRG-100107831"},{"key":"2022012815324265055_j_jpm-2017-0059_ref_017","doi-asserted-by":"crossref","unstructured":"Alfirevic Z, Roberts D, Martlew V. How strong is the association between maternal thrombophilia and adverse pregnancy outcome? a systematic review. Eur J Obs Gynecol Reprod Biol. 2002;101:6\u201314.","DOI":"10.1016\/S0301-2115(01)00496-1"},{"key":"2022012815324265055_j_jpm-2017-0059_ref_018","doi-asserted-by":"crossref","unstructured":"Infante-Rivard C, Rivard G-E, Yotov WV, G\u00e9nin E, Guiguet M, Weinberg C, et al. Absence of association of thrombophilia polymorphisms with intrauterine growth restriction. N Engl J Med. 2002;347:19\u201325.","DOI":"10.1056\/NEJM200207043470105"},{"key":"2022012815324265055_j_jpm-2017-0059_ref_019","doi-asserted-by":"crossref","unstructured":"Silver RM, Zhao Y, Spong CY, Sibai B, Wendel G, Wenstrom K, et al. Prothrombin gene G20210A mutation and obstetric complications. Obstet Gynecol. 2010;115:14\u201320.","DOI":"10.1097\/AOG.0b013e3181c88918"},{"key":"2022012815324265055_j_jpm-2017-0059_ref_020","doi-asserted-by":"crossref","unstructured":"Howley HEA, Walker M, Rodger MA. A systematic review of the association between factor V Leiden or prothrombin gene variant and intrauterine growth restriction. Am J Obstet Gynecol. 2005;192:694\u2013708.","DOI":"10.1016\/j.ajog.2004.09.011"},{"key":"2022012815324265055_j_jpm-2017-0059_ref_021","unstructured":"Franchi F, Cetin I, Todros T, Antonazzo P, Nobile de Santis MS, Cardaropoli S, et al. Intrauterine growth restriction and genetic predisposition to thrombophilia. Haematologica. 2004;89:444\u20139."},{"key":"2022012815324265055_j_jpm-2017-0059_ref_022","doi-asserted-by":"crossref","unstructured":"Verspyck E, Borg JY, Le Cam-Duchez V, Goffinet F, Degr\u00e9 S, Fournet P, et al. Thrombophilia and fetal growth restriction. Eur J Obstet Gynecol Reprod Biol. 2004;113:36\u201340.","DOI":"10.1016\/j.ejogrb.2003.06.007"},{"key":"2022012815324265055_j_jpm-2017-0059_ref_023","doi-asserted-by":"crossref","unstructured":"Vollset SE, Refsum H, Irgens LM, Emblem BM, Tverdal A, Gjessing HK, et al. Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine study. Am J Clin Nutr. 2000;71:962\u20138.","DOI":"10.1093\/ajcn\/71.4.962"},{"key":"2022012815324265055_j_jpm-2017-0059_ref_024","doi-asserted-by":"crossref","unstructured":"Wu O, Robertson L, Twaddle S, Lowe GD, Clark P, Greaves M, et al. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The thrombosis: risk and economic assessment of thrombophilia screening (TREATS) study. Health Technol Assess (Rockv). 2006;10:1\u201375.","DOI":"10.3310\/hta10110"},{"key":"2022012815324265055_j_jpm-2017-0059_ref_025","doi-asserted-by":"crossref","unstructured":"Simcox LE, Ormesher L, Tower C, Greer IA. Thrombophilia and pregnancy complications. Int J Mol Sci. 2015;16: 28418\u201328.","DOI":"10.3390\/ijms161226104"},{"key":"2022012815324265055_j_jpm-2017-0059_ref_026","doi-asserted-by":"crossref","unstructured":"Said JM, Higgins JR, Moses EK, Walker SP, Monagle PT, Brennecke SP. Inherited thrombophilias and adverse pregnancy outcomes: a case-control study in an Australian population. Acta Obstet Gynecol Scand. 2012;91:250\u20135.","DOI":"10.1111\/j.1600-0412.2011.01293.x"},{"key":"2022012815324265055_j_jpm-2017-0059_ref_027","doi-asserted-by":"crossref","unstructured":"Rodger MA, Walker MC, Smith GN, Wells PS, Ramsay T, Langlois NJ, et al. Is thrombophilia associated with placenta-mediated pregnancy complications? a prospective cohort study. J Thromb Haemost. 2014;12:469\u201378.","DOI":"10.1111\/jth.12509"},{"key":"2022012815324265055_j_jpm-2017-0059_ref_028","doi-asserted-by":"crossref","unstructured":"Lykke JA, Bare LA, Olsen J, Lagier R, Arellano AR, Tong C, et al. Thrombophilias and adverse pregnancy outcomes: results from the Danish National Birth Cohort. J Thromb Haemost. 2012;10:1320\u20135.","DOI":"10.1111\/j.1538-7836.2012.04773.x"},{"key":"2022012815324265055_j_jpm-2017-0059_ref_029","doi-asserted-by":"crossref","unstructured":"Bozikova A, Gabrikova D, Pitonak J, Bernasovska J, Macekova S, Lohajova-Behulova R. Ethnic differences in the association of thrombophilic polymorphisms with obstetric complications in Slovak and Roma (gypsy) populations. Genet Test Mol Biomarkers. 2015;19:98\u2013102.","DOI":"10.1089\/gtmb.2014.0232"},{"key":"2022012815324265055_j_jpm-2017-0059_ref_030","doi-asserted-by":"crossref","unstructured":"Lenz B, Samardzija M, Drenjancevic D, Zibar D, Samardzija M, Milostic-Srb A. The investigation of hereditary and acquired thrombophilia risk factors in the development of complications in pregnancy in Croatian women. J Matern Neonatal Med. 2016;29:264\u20139.","DOI":"10.3109\/14767058.2014.998189"}],"container-title":["Journal of Perinatal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.degruyter.com\/view\/j\/jpme.2018.46.issue-4\/jpm-2017-0059\/jpm-2017-0059.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpm-2017-0059\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpm-2017-0059\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T15:35:55Z","timestamp":1643384155000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpm-2017-0059\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,9]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,2,27]]},"published-print":{"date-parts":[[2018,5,24]]}},"alternative-id":["10.1515\/jpm-2017-0059"],"URL":"https:\/\/doi.org\/10.1515\/jpm-2017-0059","relation":{},"ISSN":["1619-3997","0300-5577"],"issn-type":[{"value":"1619-3997","type":"electronic"},{"value":"0300-5577","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8,9]]}}}